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ABSTRACT
Background: Although the importance of Papanicolaou (Pap) smear test screening in reducing the incidence of cervical cancer is
well established, in 1994–95 one in 4 women in Manitoba aged 18 to 69 years reported never having had a Pap test or not having
had a Pap test in the last 3 years. The objectives of this study were to examine the screening history of women in Manitoba
diagnosed with invasive cervical cancer and to explore whether opportunities for screening were missed.
Methods: In this case­control study women aged 18 years and older who resided in Manitoba and were diagnosed with invasive
cervical cancer between 1989 and 2001 were each matched by age and area of residence to 5 controls, (N = 4009). Conditional
logistic regression analyses were used to examine the association between Pap test utilization and the likelihood of diagnosis with
invasive cervical cancer. Generalized linear models using the negative binomial distribution were used to assess the association
between cancer status and rates of prior Pap testing and of opportunities to be screened. Logistic generalized estimating equation
models were used for the analysis of physician characteristics.
Results: Forty­six percent of women in Manitoba diagnosed with invasive cervical cancer and 67% of the control group had
received a Pap test in the 5 years before the case’s diagnosis. After adjustment for age, income and residence, the rate of Pap
testing was significantly higher in the control group (rate ratio [RR] = 1.57, 95% confidence interval [CI] 1.44–1.73). Conversely,
when cervical cancer was the outcome, women who had not had Pap tests were more likely to be diagnosed with invasive cervical
cancer (odds ratio [OR] = 2.77, 95% CI 2.30–3.30) than women who did have a Pap test. Although women diagnosed with
invasive cervical cancer had fewer Pap tests, they had had as many opportunities to be screened as controls (RR = 1.04, 95%
CI 0.96–1.12). Compared with urban family physicians, rural family physicians were less likely to provide Pap tests (OR = 0.68,
95% CI 0.58–0.80) and specialists were more likely to provide Pap tests (OR = 1.70, 95% CI 1.30–2.22).
Conclusions: Women who were diagnosed with invasive cervical cancer in the province of Manitoba, Canada, had fewer Pap tests
but the same frequency of opportunities to be screened as matched controls. These results reinforce the need to educate women
about cervical cancer screening and the importance of receiving Pap tests.
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A
LTHOUGH RATES OF CERVICAL CANCER ARE LOW IN
Canada, the incidence of the disease could be
further reduced by the detection of precursor
lesions and early­stage cancers in large populations of
asymptomatic women through screening with the
Papanicolaou (Pap) test,
1 promoting Pap testing among
women and physicians, and appropriately following up
abnormal results.
2 Despite the evidence that screening
using a Pap test decreases the incidence of cervical
cancer, and in spite of efforts to promote Pap testing, 1
in 4 women aged 18 to 69 who participated in Statistics
Canada’s 1994–95 National Population Health Survey
reported never having had a Pap test or not having a
Pap test in the last 3 years.
3
Several reasons have been identified in the literature
as to why women do not obtain cervical cancer
screening. Patient factors that influence screening
include socioeconomic and demographic
characteristics, andknowledge and attitudes about
cervical cancer.
1,4­9 The probability of being screened
tends to increase with education and income, and is
lower for non­Canadian born women, those who do not
speak English and those who have negative beliefs
about cancer.
6,8,9 System and physician factors that
influence screening include lack of regular health care,
patients’ inability to access screening services, and
missed opportunities to screen by health care
providers.
10 “Missed opportunities” are instances when
a woman has contact with a health care provider but the
provider does not perform or recommend the screening
test when it would be appropriate to do so.
10 Physician
characteristics that have been associated with missed
opportunities to provide preventive care such as a Pap
test include type of specialty, education, physician
gender and practice location.
11­14
The objectives of this study were to examine the
screening history of women diagnosed with invasive
cervical cancer, to explore whether there were missed
opportunities for screening and to investigate the
influence of physician characteristics on Pap test
utilization in the province of Manitoba.
Methods
Study design and population. This study used a case­
control design. Cases included all women 18 years of
age and older residing in Manitoba who were diagnosed
with invasive cervical cancer between 1989 and 2001.
Eighteen years of age was chosen as a cut­off, as this is
the youngest target age for the Manitoba Cervical
Cancer Screening Program. Five controls were selected
for each case. Women who had ever had cervical cancer
or malignant neoplasms, excluding non­melanoma skin
cancer, or who had had a total hysterectomy during the
study period, were excluded. Only cases and controls
who were Manitoba residents for the entire period from
1984 to 2001 were included (1984 was chosen to
provide at least 5 years of data on cases diagnosed in
1989). Cases and controls were matched by age (±1
year) at the index date, and by area of residence at the
time of the case’s diagnosis using the forward sortation
area (FSA) (i.e., the first 3 characters of the postal
code). Residence was also determined at the time of the
case’s diagnosis. Urban residence included the cities of
Winnipeg, Brandon, Portage and Thompson, each of
which has a population of at least 10  000. All other
areas of the province were considered rural. Ethics
approval was received from the Health Research Ethics
Board at the University of Manitoba and the Health
Information Privacy Committee (HIPC) at Manitoba
Health. This study was supported by a grant from the
CancerCare Manitoba Foundation.
Data sources. Cases of cervical cancer were identified
through the Manitoba Cancer Registry (MCR), while
controls were identified through the Manitoba Health
Insurance Plan Registration (MHPR) file. The MCR is a
population­based registry that records all new cancer
patients who are Manitoba residents at the time of
diagnosis. The provincial Department of Health
maintains the MHPR for the purpose of administering
the Manitoba Health Insurance Plan. Manitoba
residents are not required to pay a premium for health
insurance, which ensures that virtually everyone in the
province is included in the MHPR. A record on the
MHPR is created when a person registers with the
health insurance system. The record includes a
termination date and code when a person dies or moves
out of the province.
The Manitoba Physician Claims Database was used
to determine Pap test utilization and hysterectomy
status. This database is generated by claims filed by
physicians for payment of services and includes a
billing tariff code and the date of service. All 7 possible
Pap test tariff codes were used in this study, including
the code that laboratories use to receive payment.
Although Manitoba Pap test guidelines recommend that
women have a Pap test at least once every 2 years
following 3 consecutive normal results on annual Pap
tests,
15 we chose a 5­year interval because not all
women are screened according to the recommended
guidelines. The 5­year time frame was intended to allow
a sufficiently long interval in which screening could
take place.
Physician data — including specialty, gender,
graduation date and graduation location (Canadian v.
foreign graduate) — were abstracted from the Physician
Master File, which is a list of all Manitoba physicians
with a billing number. A brief analysis of Pap testResearch Decker et al
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frequency and physician type revealed that family
practitioners, internal medicine specialists,
obstetrician/gynecologists, general surgeons,
emergency medicine physicians and pediatricians
provided 99.99% of all Pap tests. Therefore, only
physicians in these areas of practice were included in
the study (N = 2419).
Data derived from the 1996 Canadian Census were
used to estimate the patient’s income at the time of
diagnosis by average household income per
enumeration area (approximately 500 to 600
individuals and 150 to 200 households).
Opportunity to be screened. An opportunity to be
screened was defined as any visit to a physician made
during the 5 years before the diagnosis of the case,
excluding visits that occurred fewer than 10 months
after a Pap test; any visit during this time frame was not
considered an opportunity to be screened because the
woman did not need a screening Pap test. The 6 months
before the diagnosis of the case was also excluded, to
rule out Pap tests that might have been done for
diagnostic rather than screening purposes.
Data analysis. Generalized linear regression models
using the negative binomial distribution were
conducted to assess the association between cancer
status and rates of prior Pap testing and rates of
opportunities to be screened (i.e., a matched cohort
analysis). When invasive cervical cancer was treated as
a dependent variable (i.e., case­control design), we
conducted a conditional logistic regression analysis to
examine the association between Pap test utilization
and invasive cervical cancer. We tested for an
interaction between region of residence and income,
because other research in Manitoba has found this to be
significant.
16 For analyses examining physician
characteristics, logistic generalized estimating equation
models using an independent correlation matrix to
account for correlated data within the dataset were
conducted. This allowed for unbiased estimates of the
association between the likelihood of having a Pap test
at any given visit and various physician characteristics.
Data analyses were performed using SAS Version 9.1
(SAS Institute, Cary, NC).
Results
Rate of Pap testing. A total of 4009 women were
included in the study (666 cases and 3343 controls).
The mean age at the time of diagnosis of invasive
cervical cancer was 50 years. The mean income was $39
175 for cases and $42 280 for controls. Although cases
and controls were matched by area of residence using
postal code FSAs, average income is slightly different
because it is based on enumeration areas, which are
smaller than FSAs.
In the 5­year period before the diagnosis date of the
case — excluding the 6 months before diagnosis — 63%
of all women in the study received at least one Pap test,
but this incidence was unevenly distributed between
cases and controls (Table 1). Only 46.4% of cases had
received a Pap test, compared with 66.8% of controls.
The mean number of Pap tests over the 5­year period
was 0.87 for cases and 1.38 for controls. The mean
number of Pap tests for women who had received at
least 1 Pap test was 2.62 for cases and 2.66 for controls.
After adjustment for age, income and residence, the
rate of Pap tests was found to be significantly higher for
controls than for cases (rate ratio [RR] = 1.57, 95%
confidence interval [CI] 1.44–1.73) (Table 2).The rate of
Pap tests decreased with age (RR = 0.80, 95% CI
0.78–0.81) and increased with income (RR = 1.06, 95%
CI 1.04–1.07). Region of residence was also significant:
urban women had a higher rate of Pap tests than rural
women (RR 1.22, 95% CI 1.15–1.30). However, there
was no interaction between region of residence and
income in this analysis.
Rate of cervical cancer diagnosis. Analyses of the
association between prior Pap testing and the
development of cervical cancer indicated that women
who had not had a Pap test in the 5 years before
diagnosis were more likely to be diagnosed with
invasive cervical cancer than women who had received
a Pap test during that period (odds ratio [OR] = 2.77,
95% CI 2.30–3.30) (Table 3). Increasing income had an
inverse effect on the likelihood of being diagnosed with
invasive cervical cancer (OR = 0.78, 95% CI
0.69–0.89). The analysis did not include region of
residence and age, as these variables were the basis for
matching cases and controls and therefore would have
no effect on the OR. However, an additional model
tested the interaction between residence and income
and found that the interaction was not significant.
Screening opportunities. The mean number of
opportunities to be screened in the 5 years before
diagnosis was 17.8 for cases and 18.2 for controls.
Multivariate generalized linear analysis using the
negative binomial distribution indicated no difference
between cases and controls with respect to frequency of
opportunities to be screened (RR = 1.04, 95% CI
0.96–1.12) (Table 4). Age at diagnosis and income both
had a significant effect on frequency of opportunities to
be screened; increasing age was associated with more
frequent opportunities (RR = 1.20, 95% CI 1.18–1.22),
while increasing income was associated with less
frequent opportunities (RR = 0.94, 95% CI 0.92–0.95).Research Decker et al
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Area of residence (urban v. rural) had no effect on
frequency of opportunities to be screened (RR = 1.02,
95% CI 0.96–1.09).
Physician characteristics. Compared with urban
family practitioners, rural family practitioners were less
likely (OR = 0.68, 95% CI 0.58–0.80) and specialists
more likely (OR = 1.70, 95% CI 1.30–2.22) to provide
Pap tests (Table 5).
Data on location of graduation (Canadian v.
foreign), physician gender and practice type were
available for 53% of the visits deemed an opportunity to
be screened (N = 58 029 visits). All effects were
adjusted for patient age, income and all other variables
included in the model. Compared with foreign
graduates, Canadian graduates were more likely to
provide a Pap test (OR = 1.20, 95% CI 1.04–1.39).
Female physicians were more likely to provide a Pap
test than male physicians (OR = 1.99, 95% CI
1.75–2.26). As in the first model, rural family
physicians were less likely (OR = 0.80, 95% CI
0.75–0.87) and specialists were more likely (OR = 4.39,Research Decker et al
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95% CI 4.09–4.70) to provide Pap tests than urban
family physicians.
Discussion
The Pap test is one of the most effective tools available
for the early detection of cervical cancer. However,
optimal utilization levels have still not been reached. In
this study, 36% of Manitoban women had not had a Pap
test in a 5­year period. Although the mean number of
Pap tests was slightly higher for controls in comparison
with cases, the mean number of Pap tests for women
who had received at least 1 Pap test was similar. This
finding suggests that having at least 1 Pap test increases
the likelihood of subsequent tests, and thus reinforces
the importance of ensuring that testing is initiated.
Women who had never had a Pap test were almost 3
times as likely to be diagnosed with invasive cervical
cancer as women who had received at least 1 Pap test.
However, although women diagnosed with invasive
cervical cancer had fewer Pap tests, their opportunities
to be screened were as frequent as those of study
controls.
These findings in Manitoba are consistent with
previous research that has investigated the relationship
between history of Pap test utilization and the risk of
cervical cancer; these studies also reported an increased
risk of cervical cancer for non­recipients and irregular
recipients of Pap testing.
17­21 Women who lived in urban
areas of Manitoba and those with higher incomes had
more Pap tests and a lower risk of being diagnosed with
cervical cancer. Other research has found that cervical
screening is provided more consistently in urban areas
than in rural areas, and that the incidence of Pap tests
decreases with decreasing income.
22­24 Studies in other
jurisdictions have also found that a high percentage of
women diagnosed with invasive cervical cancer had
multiple contacts with the health care system in the 3 to
5 years before diagnosis, but had not been screened for
cervical cancer.
25­28
One possible reason for our finding that controls had
as many opportunities to be screened as cases may be
that under­screened women lack continuity of care and
thus may be more likely to visit a physician for acute
problems only. In Manitoba, a steady relationship
between continuity of care and better preventive health
care has been observed.
29 Therefore, an ongoing
relationship with a family practitioner is crucial, even in
a health care system that provides universal access to
care. Conversely, although preventive services might
not traditionally be offered in walk­in clinics, these
practice settings can be successful in doing so: 55% of
patients who attended an inner­city walk­in clinic for an
acute medical problem and who were inadequately
screened accepted a same­day appointment for a Pap
test.
30 We also found that older women had more
opportunities to be screened than younger women,
likely because they visit a doctor more frequently.
Women in higher income brackets had fewer
opportunities to be screened than their counterparts in
lower income brackets. This could be because these
women do not need to visit a doctor as frequently, or
because they had been receiving Pap tests on a regular
basis, which would result in fewer of their health care
visits being counted as an opportunity to be screened.
Our study found that certain physicians were more
likely than others to provide a Pap test. The increased
provision of Pap tests by specialists (including
obstetricians/gynecologists) may relate to their specific
training, a focus on women’s health and focused
reasons for patient visits. Previous research has found
that women who see obstetricians/gynecologists are
more likely to be younger and have higher education
and income levels that those who do not see these
specialists, and therefore may request a Pap test more
frequently.
31 This is particularly worrisome, since
women are less likely to see an
obstetrician/gynecologist as they get older, yetcervical
cancer incidence and mortality rates are higher among
older women.
1 Therefore, the physicians most likely to
treat older women may be less likely to provide a Pap
test.
Patients of female physicians were also more likely
to receive Pap tests than patients of male physicians.
Female physicians have been found to devote more time
to preventive services than male physicians, even when
patient gender and health status were controlled for in
the analysis.
32­34 Patients have been shown to prefer a
physician of the same gender for genital and rectal
examinations.
32,35 However, in 1 study female patients
were no more likely to refuse an examination from a
male physician than from a female physician.
33 The
unavailability of a female chaperone may also affect
male physicians’ likelihood of providing a Pap test.
Nevertheless, obstetricians/gynecologists do not seem
to experience these screening barriers to the same
degree, based on their rates of Pap test provision.
This study has several important strengths. Many
previous studies collected data from patient and
physician surveys, introducing the possibility of non­
response, recall, interviewer and acquiescence bias.
36 By
collecting Pap test history and health care provider
information from linked Manitoba Health
administrative databases whose reliability has been
extensively evaluated, we eliminated these sources of
bias in this study. Information on all cancer cases
diagnosed over a 12­year period was available, making
the study sample very comprehensive. Information on
hysterectomy was also available, which was anResearch Decker et al
Open Medicine 2009 3(3):1 40-1 47
important limitation in previous studies that used
administrative data to examine Pap test utilization.
37
Our research, however, was not able to differentiate
between a patient refusing to have a Pap test and a
physician not offering the test. In addition, Pap tests
processed at a public laboratory from salaried
physicians who do not submit claims for the services
they provide may not be captured, which could result in
fewer Pap test being reported than were actually
performed. However, it is estimated that the physician
claims data captures at least 95% of all Pap tests
performed in Manitoba.
4,18 Data on whether a physician
was a Canadian graduate, graduation year and
physician sex were incomplete; therefore, the results
must be interpreted cautiously. Finally, a previous case­
control study that examined the screening history of
women diagnosed with invasive cervical cancer
removed cases of microinvasive cancer (International
Federation of Gynecology and Obstetrics [FIGO] stage
IA) from the main analyses because they have an
excellent prognosis and may be considered a success of
screening (most would not have been diagnosed in the
absence of screening).
21 In our study, only 15% of the
cases for whom data on available were available were
stage IA. We included stage IA cases because the
likelihood of being diagnosed with invasive cervical
cancer for women who did not have a Pap test was
much larger than for women who did have a Pap test
(OR = 2.77). If stage IA cases were removed, the effect
of not having had a Pap test would likely be even larger.
Moreover, their inclusion is unlikely to affect findings
on the opportunity to be screened because we found no
difference between the cases and controls.
Conclusion
The results of this study show that women who have
been diagnosed with invasive cervical cancer had fewer
Pap tests but had as many opportunities to be screened
as matched controls. Although some women may not
get a Pap test because they do not visit a health care
provider, a lack of contact with the health care system is
not the main reason why many women are under­
screened. These results reinforce the necessity for
health care providers to seek every opportunity to
educate women about preventive cervical cancer
screening and to provide Pap tests regardless of the
setting of care and the continuity of the relationship
with the patient.
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